Consolidated Statements of Operations - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Revenue and Other Income
Gross earned premiums		$ 146,572	$ 135,401
Ceded earned premiums		(62,637)	(38,690)
Net earned premiums		83,935	96,711
Net investment income		5,526	3,043
Net realized investment gains (losses)		(20)	(1,505)
Change in fair value of equity securities		608	403
Gain from VSRM Transaction		0	8,810
Loss portfolio transfer risk fee		0	(5,400)
Gain from sale of renewal rights		2,335	0
Other gains (losses)		0	59
Agency commission income		5,680	1,414
Other income		694	1,354
Total revenue and other income		98,758	104,889
Expenses
Losses and loss adjustment expenses, net		82,413	81,440
Policy acquisition costs		20,892	22,179
Operating expenses		17,891	18,789
Interest expense		3,206	2,971
Total expenses		124,402	125,379
Income (loss) before income taxes		(25,644)	(20,490)
Equity earnings (losses) in Affiliate, net of tax		(251)	368
Income tax expense (benefit)		9	(9,441)
Net income (loss)		(25,904)	(10,681)
Preferred stock dividends		19
Net income (loss) allocable to common shareholders		$ (25,885)	$ (10,681)
Earnings (loss) per common share, basic		$ (2.12)	$ (1)
Earnings (loss) per common share, diluted		$ (2.12)	$ (1)
Weighted average common shares outstanding, basic	[1]	12,220,511	10,692,090
Weighted average common shares outstanding, diluted	[1]	12,220,511	10,692,090

[1] The preferred shares that may be convertible into a total of 4,000,000 common shares were anti-dilutive and thus did not impact the diluted earnings per share calculation. There were no unvested restricted stock units as of December 31, 2023. The non-vested shares of the restricted stock units and stock options were anti-dilutive as of December 31, 2022. Therefore, the non-vested shares are excluded from earnings (loss) per share for the years ended December 31, 2022.